BAHAMAS

Title: Bahamas Development Corporation Approaching 52-Week High, Transforming into Cannabis Consortium

Author: MMJ Observer

Date: 9 May 2018

URL: https://www.mmjobserver.com/bahamas-development-corporation-approaching-52-week-high-transforming-into-cannabis-consortium/29434/

Extract:  

Bahamas Development Corporation Approaching 52-Week High, Transforming into Cannabis Consortium

  • Consistently releasing news, building a cannabis consortium
  • Shares up 300%+ since April 4, 2018
  • Plans to plant 15 acres of hemp to validate crop yields; show revenues

Bahamas Development Corporation (BDCI) is proving out it incubator type model in the marijuana sector and creating real shareholder value in Cannabis Consortium.

CANADA

Another big Canadian bank dips toes in marijuana sector

 

Title:  Welcome to cannabis country: A province-by-province breakdown of what to expect when marijuana becomes legal

Author: Business Financial Post

Date: 10 May 2018

URL: http://business.financialpost.com/cannabis/welcome-to-cannabis-country-a-province-by-province-breakdown-of-what-to-expect-when-marijuana-becomes-legal?mc_cid=bbffce28c2&mc_eid=178dec0b63

Extract:

Here’s a look at how the national cannabis landscape is shaping up, as of early May.

 

INDIA

How India can become a global cannabis leader: Q&A with Bombay Hemp’s Avnish Pandya

 

IRELAND

Title: Medicinal cannabis: Where does Ireland stand?. Use of these forms of cannabis is very restricted despite moves to permit limited use

Author: The Irish Times

Date: 10 May 2018

URL: https://www.irishtimes.com/news/health/medicinal-cannabis-where-does-ireland-stand-1.3490547

Extract: 

he use of medicinal forms of cannabis continues to be very restricted in Ireland in spite of moves to permit their use in limited circumstances.

Minister for Health Simon Harris commissioned a report from the Health Products Regulatory Authority (HPRA) to examine the scientific evidence on medicinal cannabis, which accepted benefits from taking medicinal cannabis for certain conditions.

After its findings were published in February 2017, the Minister announced he would implement the HPRA recommendation that cannabis-based products be made available to some patients with multiple sclerosis and epilepsy, and those suffering nausea in chemotherapy.

Restricted use, however, still applies in Ireland compared to other parts of the world – notably the United States, Canada and Australia where certified medical products are available in many instances.